American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

References

Depression in Women

AAFP CME Bulletin




  1. Wang PS, Lane M, Olfson M, et al. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629-640.
  2. Nease DE. Depression. In: Sloane PD, Slatt LM, Ebell MH, et al, eds. Essentials of Family Medicine. 6th ed. Baltimore, MD: Lippincott, Williams & Wilkins; 2011.
  3. National Institute of Mental Health. Depression. Available at http://www.nimh.nih.gov/health/publications/depression/complete-index.shtml. Accessed August 2012.
  4. National Institute of Mental Health. Statistics: Any Mood Disorder Among Adults. Available at http://www.nimh.nih.gov/statistics/1ANYMOODDIS_ADULT.shtml. Accessed August 2012.
  5. National Institute of Mental Health. Statistics: Major Depressive Disorder Among Adults. Available at http://www.nimh.nih.gov/statistics/1MDD_ADULT.shtml. Accessed August 2012.
  6. Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ). 2005;(119):1-8.
  7. Le Strat Y, Dubertret C, Le Foll B. Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. J Affect Disord. 2011;135(1-3):128-138.
  8. Viguera AC, Tondo L, Koukopoulos AE, et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry. 2011;168(11):1179-1185.
  9. Freeman EW. Associations of depression with the transition to menopause. Menopause. 2010;17(4):823-827.
  10. Henry JGA. Depression and anxiety. In: Smith MA, Shimp LA, eds. 20 Common Problems in Women’s Health Care. McGraw Hill; 2000.
  11. Bromberger JT, Kravitz HM, Chang YF, et al. Major depression during and after the menopausal transition: Study of Women’s Health Across the Nation (SWAN). Psychol Med. 2011;41(9):1879-1888. Erratum in Psychol Med. 2011;41(10):2238.
  12. Bromberger JT, Kravitz HM, Matthews K, et al. Predictors of first lifetime episodes of major depression in midlife women. Psychol Med. 2009;39(1):55-64.
  13. Stegenga BT, Nazareth I, Grobbee DE, et al. Recent life events pose greatest risk for onset of major depressive disorder during mid-life. J Affect Disord. 2012;136(3):505-513.
  14. Hirst KP, Moutier CY. Postpartum major depression. Am Fam Physician. 2010;82(8):926-933.
  15. U.S. National Library of Medicine, National Institutes of Health. MedlinePlus: Postpartum Depression. Available at http://www.nlm.nih.gov/medlineplus/ency/article/007215.htm. Accessed August 2012.
  16. Mayo Foundation for Medical Education and Research. Postpartum depression: Risk factors. Available at http://www.mayoclinic.com/health/postpartum-depression/DS00546/DSECTION=risk-factors. Accessed August 2012.
  17. Bener A, Gerber LM, Sheikh J. Prevalence of psychiatric disorders and associated risk factors in women during their postpartum period: a major public health problem and global comparison. Int J Womens Health. 2012;4:191-200.
  18. Stegenga BT, King M, Grobbee DE, et al. Differential impact of risk factors for women and men on the risk of major depressive disorder. Ann Epidemiol. 2012;22(6):388-396.
  19. U.S. Preventive Services Task Force. Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;151(11):784-792.
  20. American College of Obstetricians and Gynecologists. Committee on Obstetric Practice. Committee opinion no. 453: Screening for depression during and after pregnancy. Obstet Gynecol. 2010;115, (2 Pt 1):394-395.
  21. Hewitt C, Gilbody S, Brealey S, et al. Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis. Health Technol Assess. 2009;13(36):1-145, 147-230.
  22. Maurer DM. Screening for depression. Am Fam Physician. 2012;85(2):139-144.
  23. American Psychiatric Association. DSM-5 Development. Proposed Revision: Mood Disorders. Available at http://www.dsm5.org/ProposedRevisions/Pages/MoodDisorders.aspx. Accessed August 2012.
  24. American Psychiatric Association. DSM-5 Development. Proposed Revision: Depressive Disorder Not Otherwise Specified. Available at http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=47. Accessed August 2012.
  25. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. In: National Guideline Clearinghouse. Rockville, MD: Agency for Healthcare Research and Quality. Available at http://www.guideline.gov/content.aspx?id=24158. Accessed August 2012.
  26. Vigod SN, Ross LE, Steiner M. Understanding and treating premenstrual dysphoric disorder: an update for the women’s health practitioner. Obstet Gynecol Clin North Am. 2009;36(4):907-924, xii.
  27. Nordentoft M. Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups. Dan Med Bull. 2007;54(4):306-369.
  28. Garvey KA, Penn JV, Campbell AL, et al. Contracting for safety with patients: clinical practice and forensic implications. J Am Acad Psychiatry Law. 2009;37(3):363-370.
  29. National Collaborating Centre for Mental Health Depression. The treatment and management of depression in adults. In: National Guideline Clearinghouse. Rockville, MD: Agency for Healthcare Research and Quality. Available at http://www.guideline.gov/content.aspx?id=15521. Accessed August 2012.
  30. Thota AB, Sipe TA, Byard GJ, et al; Community Preventive Services Task Force. Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis. Am J Prev Med. 2012;42(5):525-538.
  31. Dennis CL, Ross LE, Grigoriadis S. Psychosocial and psychological interventions for treating antenatal depression. Cochrane Database Syst Rev. 2007;(3):CD006309.
  32. Jakobsen JC, Hansen JL, Simonsen S, et al. Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial sequential analyses. Psychol Med. 2012;42(7):1343-1357.
  33. Henken HT, Huibers MJ, Churchill R, et al. Family therapy for depression. Cochrane Database Syst Rev. 2007;(3):CD006728.
  34. Barbato A, D’Avanzo B. Marital therapy for depression. Cochrane Database Syst Rev. 2006;(2):CD004188.
  35. Mead GE, Morley W, Campbell P, et al. Exercise for depression. Cochrane Database Syst Rev. 2009;(3):CD004366.
  36. Maratos AS, Gold C, Wang X, et al. Music therapy for depression. Cochrane Database Syst Rev. 2008;(1):CD004517.
  37. Jorm AF, Morgan AJ, Hetrick SE. Relaxation for depression. Cochrane Database Syst Rev. 2008;(4):CD007142.
  38. Arroll B, Elley CR, Fishman T, et al. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev. 2009;(3):CD007954.
  39. Hetrick S, Merry S, McKenzie J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev. 2007;(3):CD004851.
  40. U.S. Food and Drug Administration. Antidepressant Use in Children, Adolescents, and Adults. Available at http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm096273.htm. Accessed August 2012.
  41. Fooladi E, Bell RJ, Davis SR. Management strategies in SSRI-associated sexual dysfunction in women at midlife. Climacteric. 2012;15(4):306-316.
  42. Vermeiden M, van den Broek WW, Mulder PG, et al. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients. J Psychopharmacol. 2010;24(4):497-502.
  43. Drevets WC, Furey ML. Replication of scopolamine’s antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol Psychiatry. 2010;67(5):432-438.
  44. Furey ML, Khanna A, Hoffman EM, et al. Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacology. 2010;35(12):2479-2488.
  45. Organization of Teratology Information Specialists. Fluoxetine (Prozac®) and Pregnancy. Available at http://www.otispregnancy.org/files/fluoxetine.pdf. Accessed August 2012.
  46. Linde K, Berner MM, Kriston L. St John’s wort for major depression. Cochrane Database Syst Rev. 2008;(4):CD000448.
  47. Henderson L, Yue QY, Bergquist C, et al. St John’s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol. 2002;54(4):349-356.
  48. Carpenter DJ. St. John’s wort and S-adenosyl methionine as “natural” alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit? Altern Med Rev. 2011;16(1):17-39.
  49. Papakostas GI, Mischoulon D, Shyu I, et al. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am J Psychiatry. 2010;167(8):942-948.
  50. Shaw K, Turner J, Del Mar C. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev. 2002;(1):CD003198.
  51. Smith CA, Hay PP, MacPherson H. Acupuncture for depression. Cochrane Database Syst Rev. 2010;(1):CD004046.
  52. Howland RH. Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes. J Psychosoc Nurs Ment Health Serv. 2008;46(10):21-24.
Shop Catalog